JP2005522432A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005522432A5 JP2005522432A5 JP2003565480A JP2003565480A JP2005522432A5 JP 2005522432 A5 JP2005522432 A5 JP 2005522432A5 JP 2003565480 A JP2003565480 A JP 2003565480A JP 2003565480 A JP2003565480 A JP 2003565480A JP 2005522432 A5 JP2005522432 A5 JP 2005522432A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- composition according
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 4
- 239000002464 receptor antagonist Substances 0.000 claims 3
- 229940044551 receptor antagonist Drugs 0.000 claims 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- LOCQRDBFWSXQQI-UHFFFAOYSA-N 5-chloro-n-(4-methoxy-3-piperazin-1-ylphenyl)-3-methyl-1-benzothiophene-2-sulfonamide Chemical group COC1=CC=C(NS(=O)(=O)C2=C(C3=CC(Cl)=CC=C3S2)C)C=C1N1CCNCC1 LOCQRDBFWSXQQI-UHFFFAOYSA-N 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- ATKZKAYWARYLBW-UHFFFAOYSA-N n-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide Chemical group COC1=CC=C(S(=O)(=O)NC=2C(=C(Cl)C=C(Cl)C=2)OC)C=C1N1CCNCC1 ATKZKAYWARYLBW-UHFFFAOYSA-N 0.000 claims 1
- 230000007514 neuronal growth Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0202680A GB0202680D0 (en) | 2002-02-05 | 2002-02-05 | Novel method |
| GB0222616A GB0222616D0 (en) | 2002-09-30 | 2002-09-30 | Novel method |
| PCT/GB2003/000462 WO2003066056A1 (en) | 2002-02-05 | 2003-02-04 | Method of promoting neuronal growth |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005522432A JP2005522432A (ja) | 2005-07-28 |
| JP2005522432A5 true JP2005522432A5 (cg-RX-API-DMAC7.html) | 2006-03-16 |
Family
ID=27736189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003565480A Withdrawn JP2005522432A (ja) | 2002-02-05 | 2003-02-04 | ニューロン成長の促進方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20070270432A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1471912A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005522432A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003244452A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003066056A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR039127A1 (es) | 2002-03-27 | 2005-02-09 | Glaxo Group Ltd | Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento |
| JP4571507B2 (ja) | 2002-12-18 | 2010-10-27 | スベン ライフ サイエンシズ リミティド | セロトニン受容体親和性を有する四環系3−置換インドール |
| NZ544331A (en) | 2003-07-22 | 2010-03-26 | Arena Pharm Inc | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| ATE430752T1 (de) | 2004-01-02 | 2009-05-15 | Suven Life Sciences Ltd | Neue indenoä2,1-aüindene und isoindolä2,1-aüindol |
| US7713954B2 (en) | 2004-09-30 | 2010-05-11 | Roche Palo Alto Llc | Compositions and methods for treating cognitive disorders |
| US7998981B2 (en) | 2005-08-12 | 2011-08-16 | Suven Life Sciences Limited | Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands |
| US7923566B2 (en) | 2005-08-16 | 2011-04-12 | Suven Life Sciences Limited | Alternative process for the preparation of losartan |
| CN101553467B (zh) | 2007-01-08 | 2011-12-07 | 苏文生命科学有限公司 | 5-(杂环基)烷基-n-(芳基磺酰基)吲哚化合物及其作为5-ht6配体的用途 |
| WO2008091863A1 (en) | 2007-01-23 | 2008-07-31 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
| AU2008246947B2 (en) | 2007-05-03 | 2011-03-31 | Suven Life Sciences Limited | Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands |
| CA2703157C (en) | 2007-10-26 | 2013-02-05 | Suven Life Sciences Limited | Amino arylsulfonamide compounds and their use as 5-ht6 ligands |
| EP2254564A1 (en) | 2007-12-12 | 2010-12-01 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US8318725B2 (en) | 2008-09-17 | 2012-11-27 | Suven Life Sciences Limited | Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands |
| MX2011002884A (es) | 2008-09-17 | 2011-04-21 | Suven Life Sciences Ltd | Compuestos de aril-sulfonamida-amina y su uso como ligandos de 5-ht6. |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| MX2012007783A (es) | 2010-01-05 | 2012-10-03 | Suven Life Sciences Ltd | Compuestos sulfona que actuan como ligandos del receptor 5-ht6. |
| KR101608499B1 (ko) | 2013-10-08 | 2016-04-01 | 이화여자대학교 산학협력단 | 4-니트로인돌 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 5-ht6 수용체 관련 질환의 예방 또는 치료용 약학적 조성물 |
| JP2018516992A (ja) | 2015-06-12 | 2018-06-28 | アクソファント サイエンシーズ ゲーエムベーハーAxovant Sciences Gmbh | レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体 |
| CN108472285A (zh) | 2015-07-15 | 2018-08-31 | 阿速万科学有限责任公司 | 用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ2376A1 (fr) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
-
2003
- 2003-02-04 WO PCT/GB2003/000462 patent/WO2003066056A1/en not_active Ceased
- 2003-02-04 US US10/503,679 patent/US20070270432A1/en not_active Abandoned
- 2003-02-04 AU AU2003244452A patent/AU2003244452A1/en not_active Abandoned
- 2003-02-04 JP JP2003565480A patent/JP2005522432A/ja not_active Withdrawn
- 2003-02-04 EP EP03737355A patent/EP1471912A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20161657T1 (hr) | Kinazolinoni kao inhibitori humane fosfatidilinozitol 3- kinaze delta | |
| WO2006023460A3 (en) | COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY | |
| MY148487A (en) | Biphenyl derivatives | |
| CA2364718A1 (en) | Monoamine reuptake inhibitors for treatment of cns disorders | |
| JP2006526031A5 (cg-RX-API-DMAC7.html) | ||
| MY130803A (en) | New quinuclidine amide derivatives | |
| LU92520I2 (fr) | Bédaquiline, ou son sel d'addition d'acide ou de base pharmaceutiquement acceptable, y compris le fumarate de bédaquiline | |
| WO2007048066A3 (en) | Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators | |
| GEP20094723B (en) | Tetraazabenzo [e] azulene derivatives and analogs thereof | |
| JP2007521280A5 (cg-RX-API-DMAC7.html) | ||
| NO20050883D0 (no) | Ny fremgangsmate for syntesen (IS)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| ATE442135T1 (de) | 5ht2c-rezeptor-modulator-zusammensetzungen und anwendungsverfahren | |
| EP1741712A3 (en) | Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of Nebivolol | |
| EP2397476A3 (en) | Indole derivative having PGD2 receptor antagonist activity | |
| JP2005504782A5 (cg-RX-API-DMAC7.html) | ||
| FR2882556B1 (fr) | Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent | |
| DE60302157D1 (de) | Opioidrezeptorantagonisten | |
| JP2008513510A5 (cg-RX-API-DMAC7.html) | ||
| WO2006066173A3 (en) | Novel mch receptor antagonists | |
| JP2004532828A5 (cg-RX-API-DMAC7.html) | ||
| BR0316895A (pt) | Composto, processo para a preparação do composto, composição farmacêutica, novos intermediários, processo para a preparação dos novos intermediários e uso do composto | |
| WO2007039462A3 (en) | Indane derivatives as mch receptor antagonists | |
| RU2000100362A (ru) | Применение специфического антагониста 5нт2 рецепторов для приготовления лекарств, пригодных для лечения синдрома апноэ во сне | |
| NO20050888D0 (no) | Ny fremgangsmate for syntesen av 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| NO20063602L (no) | Benzyl(iden)-laktam-derivater |